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Consensus covariation-based secondary structural models for the 5 140 nucleotides of the 5 untranslated
regions (5UTRs) from mouse hepatitis virus (MHV) and severe acute respiratory syndrome coronavirus
(SCoV) were developed and predicted three major helical stem-loop structures, designated stem-loop 1 (SL1),
SL2, and SL4. The SCoV 5UTR was predicted to contain a fourth stem-loop, named SL3, in which the leader
transcriptional regulatory sequence (TRS) is folded into a hairpin loop. cDNAs corresponding to MHV/SCoV
chimeric genomes were constructed by replacing the complete MHV 5UTR with the corresponding SCoV
sequence and by separately replacing MHV 5UTR putative SL1, putative SL2, TRS, and putative SL4 with the
corresponding SCoV sequences. Chimeric genomes were transcribed in vitro, and viruses were recovered after
electroporation into permissive cells. Genomes in which the MHV 5UTR SL1, SL2, and SL4 were individually
replaced by their SCoV counterparts were viable. Chimeras containing the complete SCoV 5UTR or the
predicted SCoV SL3 were not viable. A chimera containing the SCoV 5UTR in which the SCoV TRS was
replaced with the MHV TRS was also not viable. The chimera containing the entire SCoV 5UTR failed to direct
the synthesis of any virus-specific RNA. Replacing the SCoV TRS with the MHV TRS in the MHV/5UTR SCoV
chimera permitted the synthesis of minus-sense genome-sized RNA but did not support the production of
positive- or minus-sense subgenomic RNA7. A similar phenotype was obtained with the MHV/SCoV SL3
chimera. These results suggest a role for the TRS in the replication of minus-sense genomic RNA in addition
to its known function in subgenomic RNA synthesis.
The coronavirus (CoV) family is a group of enveloped RNA
viruses that infect diverse species of mammals, causing respi-
ratory, gastrointestinal, and neurologic disease (18). Prior to
2002, human coronaviruses (HCoV) were primarily thought of
as upper respiratory pathogens, accounting for approximately
30% of common colds. In late 2002, a novel CoV emerged in
southern China to cause severe acute respiratory syndrome, a
disease with 10% mortality. This outbreak rapidly spread to all
continents and, in addition to its threat to public health, pro-
duced large economic dislocations in affected regions (31).
Although no human cases of severe acute respiratory syn-
drome CoV (SCoV) infection have been reported since 2004,
the virus remains a threat to reemerge by transmission from its
likely natural host, wild bats (19). Even more recently, two new
human coronaviruses, HCoV-NL63 and HCoV-HKU1, were
identified as common causes of upper and lower respiratory
disease (34, 36).
Coronavirus-infected cells contain 6 to 11 distinct RNA spe-
cies (18). The intracellular RNAs form a nested set with com-
mon 3 ends, with the longest RNA being the intracellular
counterpart of the virion RNA (1). For mouse hepatitis virus
(MHV), the 21-kb-long gene 1 contains two open reading
frames (ORF1a and ORF1b); a 1 ribosomal frameshift dur-
ing translation (2) results in the synthesis of a putative 7,178-
amino-acid ORF1ab polyprotein. The resulting 740-kDa
polypeptide contains a conserved array of functional domains:
papain-like cysteine protease(s), ADP-ribose-1-monophos-
phate-processing enzyme (X domain), a two--barrel-fold (pi-
cornavirus 3C-like) main protease, RNA-dependent RNA
polymerase, zinc-binding domain-containing helicase, putative
exoribonuclease, endoribonuclease, and ribose-2-O-methyl-
transferase domains (23).
The coronaviruses have been classified into three subgroups,
termed group 1, group 2, and group 3, based on serologic
relatedness, genetic organization, and sequence similarity (30).
SCoV was originally placed in its own unique group by primary
genomic analysis (27). Although somewhat controversial, more
recent phylogenetic studies using a variety of software tools
and comparing a more extensive set of amino acid sequences
than those used in the original analysis (ORF1a, ORF1b, spike
[S], envelope [E], membrane [M], and nucleocapsid [N]) re-
vealed that SCoV is best placed as an early branch of the group
2 coronaviruses (9, 30, 38). This group contains MHV (one of
the best-characterized coronaviruses), human respiratory coro-
navirus (HCoV-OC43), and bovine coronavirus (BCoV),
among others.
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Coronavirus untranslated regions (UTRs) contain cis-acting
sequences and structures known to play essential roles in RNA
synthesis, gene expression, and virion assembly (6, 10, 16).
Although coronaviruses of the same species recombine with
high frequency (22), only a few studies have examined the
ability of different coronaviruses to recombine (10, 13). Based
on the conservation of secondary structures (a bulged stem-
loop and an adjacent pseudoknot) in the 3 untranslated re-
gions (3UTRs) of all group 2 coronaviruses, functional studies
have shown that the MHV 3UTR can be functionally replaced
with the 3UTRs from BCoV (13) and SCoV (10). Previously,
others have partially characterized four stem-loop structures (I
to IV) in the BCoV 5UTR (5, 24, 25). Many of the features of
this secondary structural model of the BCoV 5UTR are sup-
ported by enzymatic structure probing and defective interfer-
ing (DI) RNA replication experiments. Somewhat surprisingly,
stem-loops I and II do not have precise higher-order counter-
parts in the group 1 and group 3 coronaviruses. In this report,
we present an alternative consensus secondary structural
model of the coronavirus 5UTRs (Fig. 1A) (17, 21). The
model was developed by covariation analysis of a multiple
sequence alignment of the 5 140 nucleotides (nt) of the
5UTRs from nine coronaviruses from all three subgroups and
is supported by a variety of RNA secondary structure predic-
tion algorithms (7, 12, 26, 40) as well as nuclear magnetic
resonance (NMR) analyses and genetic studies (P. Liu et al.,
FIG. 1. Predicted secondary structures within the 140-nt 5UTR of the MHV and SCoV genomes (see the text for details). Previously described
predicted stem-loops 1 (SL1) (boldface and italic type), 2 (SL2) (large font and italics), and 4 (SL4) (large font) in the 5UTRs are noted (17, 21).
MHV leader TRS CS (boldface, underlined type) is contained within the linear sequence between SL2 and SL4. However, the SCoV leader TRS
CS (boldface, underlined type) is contained within stem-loop 3 (SL3) (boldface type). The AUGs shown represent the start codons of nsp1 in the
MHV (nt 210 to 212) and SCoV (nt 265 to 267) genomes. • indicates noncanonical base pairings. (B) SL2 sequence alignment of group 2
coronaviruses. The stem portion of SL2 is underlined; the U-turn motif is italicized;  indicates absolutely conserved nucleotides. SL2 sequences
of MHV (GenBank accession no. NC_001846), SCoV (accession no. AY278741), BCoV (accession no. NC_003045), HCoV-OC43 (accession no.
NC_005147), HCoV-HKU1 (accession no. NC_006577), HCoV-NL63 (accession no. NC_005831), HCoV-229E (accession no. NC_002645),
TGEV (accession no. NC_002306), and IBV (accession no. NC_001451) are relative to the corresponding viral genomes in GenBank.
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TABLE 1. Primers used in this study
Primer Sequence (5–3)a Location(s)
Oligonucleotide A59() 14639-14658 GTGGATACACATCGTTATCG MHV 14639–14658
Oligonucleotide A59() 16038-16059 ATGAAGTCTACCTTCCATACCC MHV 16038–16059
Oligonucleotide A59() 16596-16577 TACTGTGGTTTATGGTCCTC MHV 16596–16577
MHV 5 1-20 () primer TATAAGAGTGATTGGCGTCC MHV 1–20
SCoV 5 1-20 () primer TTATTAGGTTTTTACCTACCCAG SCoV 1–20
7065 () primer CATTGCAGGAATAGTACCC MHV 31288–31270
N () primer GGCACTCCTTGTCCTTCT MHV 29937–29920
7059 () oligonucleotide 8 CTGGTGTTACACAGGCAGCGCGTCGGCATGTAATAC
GACTCACTATAGA
MHV 611–628
P1A-Forc,e,f TAAGAGTGATTGGCGTCCGTACGTACCC MHV 1–30
P2A-Forc pTCTCAACTCTAAAACTCTTGTAGTTTAAATCTA MHV 31–63
P3A-Ford,f pATCTAAACTTTATAAACGGCACTTCCTGCGTGTCCAT
GCCCGC
MHV 64–106
P1A-Reve,f pTCACTCTTATCTATAGTGAGTCGTATTACATGCCGA T7 promoter in plasmid A
P2A-Rev pCGTTTATAAAGTTTAGATTAGATTTAAACTACAAGA
GTTTTAGAGTTGAGAGGGTACGTACGGACGCCAA
MHV 81–12
P3A-Revd,e,f GGGCATGGACACGCAGGAAG MHV 104–85
P2A-For (swap TRS)e pTCTCAACTCTAAAACTCTTGTAGTTTAAGTTCT MHV 31–58, SCoV 58–62
P3A-For (swap TRS)e pCTAAACGAACTATAAACGGCACTTCCTGCGTGTCCAT
GCCCGC
MHV 74–106, SCoV
63–73
P2A-Rev (swap TRS)e pTGCCGTTTATAGTTCGTTTAGAGAACTTAAACTACAA
GAGTTTTAGAGTTGAGAGGGTACGTACGGACG
CCAA
MHV 74–84 and 12–58,
SCoV 58–72
P2A-SL2-Forf pTCTCAACTCTAGATCTCTTGTAGATCAAATCTA MHV 31–41 and 57–63,
SCoV 42–56
P2A-SL2-Revf pTGCCGTTTATAAAGTTTAGATTAGATTTGATCTACAA
GAGATCTAGAGTTGAGAGGGTACGTACGGACG
CCAA
MHV 84–57 and 41–12,
SCoV 56–42
MluI-T7-F AAAACGCGTCGGCATGTA T7 promoter
SL4-only-BsmBI-Fg TTTTCGTCTCTGTTCCTTGACTTTCGTTCTCT MHV 140–160
SL4-only-BsmBI-Rg TTTCGTCTCGGAACTTTATACTGCGTAGGTGC MHV 140–143, SCoV
130–113
b/wSL4-AUG-BsmBI-Fh CTTCGTCTCACAATAATAAATTTTACTG SCoV 131–148
b/wSL4-AUG-BsmBI-Rh AAACGTCTCAATTGTACAAATGTCAGCACTAT MHV 122–139, SCoV
134–131
7131-5-U1 (SL1)d CGCGTCGGCATGTAATACGACTCACTATAGTTATTAG
GTTTTTACCTACC
SCoV 1–20
7131-5-U2 (SL1)d CAGGAAAAGCCAACCAAAACTCTTGTAGTTTAAATCTA MHV 41–63, SCoV 21–35
7131-5-D1 (SL1)d TTTTGGTTGGCTTTTCCTGGGTAGGTAAAAACCTAATAA
CTATAGTGAGTCGTATTACATGCCGA
MHV 44–41, SCoV 35–2
7131-5-D2 (SL1)d TGCCGTTTATAAAGTTTAGATTAGATTTAAACTACA
AGAG
MHV 84–45
17TG TTTTTTTTTTTTTTTTTG MHV 31351–31334
S 5UTR RT primer CGTTCACGACTCAGTATCTC SCoV 1637–1618
7131-2-U1b CGCGTCGGCATGTAATACGACTCACTATAGATATTAG
GTTTTTAC
SCoV 1–15
7131-2-U2b pCTACCCAGGAAAAGCCAACCAACCTCGATCTCTTGTAG
ATCTGTTCTCTAATCTAAAC
MHV 65–71, SCoV 16–66
7131-2-U3b pTTTAAAATCTGTGTAGCTGTCGCTCGGCTGCATGCCTA
GTGCACC
SCoV 73–117
7131-2-U4b pTACGCAGTATAAACAATAATAAATTTTACTGTCGTTGAC
AAGAAACGAGTAACTCGT
SCoV 118–174
7131-2-U5b pCCCTCTTCTGCAGACTGCTTACGGTTTCGTCCGTGTTG
CAGTCGATCATCAGCATAC
SCoV 175–231
7131-2-D1b TGGCTTTTCCTGGGTAGGTAAAAACCTAATAACTATAGT
GAGTCGTATTACATGCCGA
SCoV 32–1
7131-2-D2b pCTACACAGATTTTAAAGTTTAGATTAGAGAACAGATCT
ACAAGAGATCGAGGTTGGT
MHV 71–65, SCoV 88–73
and 66–33
7131-2-D3b pTTGTTTATACTGCGTAGGTGCACTAGGCATGCAGCCGA
GCGACAG
SCoV 133–89
Continued on facing page
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unpublished data; L. Li and D. Giedroc, unpublished data).
This model predicts three stem-loops, SL1, SL2, and SL4, that
are structurally conserved among the group 1 and group 2
coronaviruses, including SCoV. Putative SL2 contains a (C/U)
UUG(U/C) pentaloop sequence that is the most highly con-
served contiguous run of nucleotides in the entire 5UTR out-
side of the core transcriptional regulatory sequence (TRS),
and covariation analysis reveals that this loop is always stacked
on a 5-bp helix (Fig. 1B). SCoV is predicted to have an addi-
tional putative stem-loop structure (SL3) that contains both
the SCoV TRS (ACGAAC) (15, 32) and MHV TRS (UCUA
AAC) core sequences (CSs) (3, 28). Although 5UTRs of the
group 2 coronaviruses have a high degree of sequence similar-
ity and are predicted to have similar secondary structures, to
date, no study has investigated the ability of various 5UTRs or
portions of the UTRs from different species of coronaviruses
to function in the context of a heterologous coronavirus ge-
nome. Studies on the ability of the SCoV 5UTR to function in
the background of the MHV genome are likely to be informa-
tive regarding the suggested phylogenetic relationship between
these two viruses (30) and may indicate the potential for re-
combination between a significant human pathogen, SCoV,
and related animal coronaviruses.
In this work, we examine the ability of SCoV/MHV chimeric
genomes to support viral replication. Chimeric genomes were
created by individually inserting SCoV-encoded putative stem-
loops SL1, SL2, and SL4 and the TRS CS in place of their
MHV counterparts in the context of an otherwise wild-type
(WT) MHV-A59 genome. Using a recently developed reverse
genetic system (37), full-length cDNAs of the MHV-A59 ge-
nome were assembled to construct SCoV/MHV chimeric ge-
nomes. The chimeric genomes were generated in vitro, and
their viability, growth kinetics, and ability to direct the synthe-
sis of virus-specific RNAs were determined.
MATERIALS AND METHODS
Virus and cells. DBT cells were maintained at 37°C and 5% CO2 in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% calf serum (Hy-
Clone, Logan, UT). L2 cells were maintained at 37°C and 3% CO2 in DMEM
supplemented with 10% calf serum. Baby hamster kidney 21 cells expressing the
MHV receptor (BHK-R) were grown in DMEM supplemented with 10% calf
serum and G418 (800 g/ml) to select for cells expressing the MHV receptor
(37). MHV-A59 1000 (37) was used as a wild-type control virus for comparison
with chimeric viruses.
Assembly of a full-length MHV-A59 infectious construct. The reverse genetic
system for MHV-A59 used in this study was initially described by Yount et al.
(37). cDNAs representing the entire MHV-A59 genome with either the wild-type
sequence or the MHV/SCoV chimeric sequences were constructed by ligation of
the A (or G) fragments to fragments (A)B to G(F) as described previously (37).
Chimeric and wild-type MHV genomes were transcribed and electroporated into
cells as previously described (37). Cultures were observed for up to 72 h for the
development of a cytopathic effect (CPE) (cell fusion) and harvested by freezing
at 70°C. Cultures that did not develop a CPE were blind passaged three times
through DBT cells in a further attempt to recover infectious virus. At least three
independent experiments, including at least one experiment in which electropo-
rated cells were incubated at 34°C and 40°C, were performed before a mutant
genome was considered nonviable.
Plasmid constructions. The primers used in this study are listed in Table 1.
The A plasmid of the MHV reverse genetic system described previously by
Yount et al. (37) was utilized as a basis for constructing a fusion of the SCoV
5UTR to the MHV gene 1 coding sequence. The strategy employed to construct
this fusion exploited “no see’m” technology to eliminate a BsmBI restriction site
engineered into the end of DNA fragments by PCR (37). Briefly, the entire
SCoV 5UTR was amplified from purified SCoV RNA (Urbani strain) (27),
obtained from the Center for Disease Control and Prevention (CDC), by reverse
transcription (RT)-PCR using primers that contained additional BsmBI sites (S
5UTR swap oligonucleotides 3 and 7). The resultant RT-PCR product was TA
cloned into the pGEM-T vector (Promega) to produce plasmid 0A-1, maintain-
ing the BmsBI sites. Plasmid 0A-2 was produced by subcloning a BamHI frag-
ment from the A plasmid of the MHV reverse genetic system into the PCR-XL-
TOPO vector (Invitrogen). This BamHI fragment contained a small portion of
the A plasmid backbone, a T7 promoter, and the first 252 nt of the MHV
genome, extending into the MHV gene 1 coding region. The MHV 5UTR was
removed from plasmid 0A-2 by inverse PCR with Pfx DNA polymerase (Invitro-
gen) using primers that contained BsmBI sites (S 5UTR swap oligonucleotides
5 and 6), followed by self-ligation to produce plasmid 0A-3. The SCoV 5UTR
TABLE 1—Continued
Primer Sequence (5–3)a Location(s)
7131-2-D4b pAGTCTGCAGAAGAGGGACGAGTTACTCGTTTCTTGTCA
ACGACAGTAAAATTTATTA
SCoV 190–134
7131-2-D5b CTAGGTATGCTGATGATCGACTGCAACACGGACGAAAC
CGTAAGC
SCoV 235–191
7131-4-U1c pATCTAAACTTTTTAAAATCTGTGTAGCTGTCGCTCGGC
TGCATGCCTAGTGCACC
MHV 64–73, SCoV
73–117
7131-4-D1c pCTACACAGATTTTAAAAAGTTTAGATTAGATTTAAACT
ACAAGAGTTTTAGAGTTGAGAGGGTACGTACGGA
MHV 18–73, SCoV 73–88
Oligonucleotide 1 CCCCCCCGTCTCTTTACACATTAGAGTCATCTTCTA MHV 31011–31034
Oligonucleotide 2 CCCCCCCGTCTCATGACAAAAAAAAAAAAAAAAAA SCoV 29727–29723
Oligonucleotide 3 CCCCCCCGTCTCTGTAAACACTCATGATGACCACA pGEM-T vector region
Oligonucleotide 4 CCCCCCCGTCTCAGTCATTCTCCTAAGAAGCTATTA pGEM-T vector region
S 5UTR swap oligonucleotide 3 TTTCCCCGTCTCTTATTAGGTTTTTACCTACCCAG SCoV 1–23
S 5UTR swap oligonucleotide 7 TTTCCCCGTCTCACATCTTACCTTTCGGTCACACCC SCoV 245–267
S 5UTR swap oligonucleotide 5 (C)7GTCTCAAATAACTATAGTGAGTCGTATTACATGC PCR-XL-TOPO region
S 5UTR swap oligonucleotide 6 (T)6CGTCTCAGATGGCAAAGATGGGCAAATACGGT PCR-XL-TOPO region
a p indicates the 5-phosphorylated nucleotide in each primer. SCoV sequence regions are set in italics.
b The HK1A mutated region (MluI-AvrII fragment) was produced by the annealing of primers 7131-2-U1 through 7131-2-U5 and 7131-2-D1 through 7131-2-D5.
c HK4A; P1A-For, P2A-For, 7131-4-U1, 7131-2-U4, 7131-2-U5, P1A-Rev, 7131-4-D1, 7131-2-D3, 7131-2-D4, and 7131-2-D5.
d HK5A; 7131-5-U1, 7131-5-U2, P3A-For, 7131-5-D1, 7131-5-D2, and P3A-Rev.
e HK12A; P1A-For, P2A-For (swap TRS), P3A-For (swap TRS), P1A-Rev, P2A-Rev (swap TRS), and P3A-Rev.
f HK18A; P1A-For, P2A-SL2-For, P3A-For, P1A-Rev, P2A-SL2-Rev, and P3A-Rev.
g No see’m technology was conducted to generate the HK8A mutated region using these primers.
h No see’m technology was conducted to generate the HK11A mutated region using these primers.
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was excised from plasmid 0A-1 by BsmBI digestion and ligated with BsmBI-
digested plasmid 0A-3 to produce plasmid 7074. This ligation eliminated the
BsmBI sites and precisely fused the SCoV 5UTR to the MHV gene 1 coding
sequence. After sequencing to verify the construction, a restriction fragment
exchange was performed to replace the 550-bp BamHI fragment in MHV plas-
mid A with the 620-bp BamHI fragment containing a T7 promoter plus the
SCoV 5UTR fused to 252 nt of the MHV gene 1 coding sequence. This chimeric
plasmid was called pHK0A and could be used in the MHV reverse genetic system
FIG. 2. Schematic diagram depicting the major constructs used throughout this study. Both the names of the recombinant genomes and plasmids (in
parentheses) used to construct these chimeric genomes are shown. The predicted stem-loop structures in the 5 140 nt of MHV and SCoV are indicated
in the schematic. The positions of the first and last nucleotides are indicated below the boxes depicting the predicted stem-loops. The complete 5UTR
and 3UTR of SCoV are represented by open rectangles. Single-stranded regions derived from SCoV and MHV are indicated by the thick and thin lines,
respectively. The sequences of the 5UTRs of MHV, SCoV, and each of the chimeric genomes used in this study are shown. SCoV-derived nucleotides
are underlined. Boldface type indicates a predicted single-stranded region between the first nucleotide and the predicted 3 end of SL4. Italicized
sequenced are predicted to fold into the stem-loop structures as labeled above the italicized sequences. Bold dashes indicate transitions from predicted
stem-loops to single-stranded regions. Sequences 3 to SL4 are shown in lightface type and are not encompassed by our structural model.
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in place of plasmid A. A similar strategy was used to replace the MHV 3UTR
with the SCoV 3UTR (27) in the MHV reverse genetic system G plasmid. The
SCoV 3UTR and 15 nt of the poly(A) tail were amplified from purified SCoV
RNA (27) by RT-PCR using primers that contained BsmBI sites (oligonucleo-
tides 1 and 2), which could subsequently be eliminated during ligation, and
cloned (plasmid 0G-1). In plasmid 0G-1, the MHV-A59 sequences between an
ApaI site at position 30072 (relative to the MHV-A59 genome) (GenBank
accession no. NC_001846) (39) and a PacI site inserted just downstream of the
poly(A) tail were derived from plasmid B36 (14). Inverse PCR (oligonucleotides
3 and 4) was utilized to produce plasmid 0G-2, replacing the MHV 3UTR with
two BsmBI sites separated by a small spacer sequence. After digestion by the
BsmBI restriction enzyme, the plasmid 0G-1 fragment containing the SCoV
3UTR was ligated into BsmBI-digested plasmid 0G-2 to eliminate the BsmBI
sites, producing plasmid 0G-3. This plasmid contained a fusion of the last 969 nt
of the N coding sequence to the SCoV 3UTR. This was then transferred to the
MHV genetic system G plasmid by restriction fragment exchange to produce a
plasmid called pMF0G.
Site-directed mutagenesis. Site-directed mutagenesis was performed to intro-
duce mutations into pHK0A or plasmid A using an oligonucleotide assembly
strategy (8). Overlapping oligonucleotides were designed to span the sequence
regions between MluI and SacII (131 nt, which includes the MHV-A59 sequence
at positions 1 to 106) in plasmid A or between MluI and AvrII (256 nt, which
includes the SCoV sequence at positions 1 to 231) in pHK0A and, after anneal-
ing, to have MluI and SacII or MluI and AvrII overhangs at their 5 and 3 ends.
The annealed oligonucleotides were ligated, and the resulting DNA fragment
was purified and then ligated into MluI- and SacII-cut plasmid A or MluI- and
AvrII-cut pHK0A to create chimeric plasmids. Schematic drawings of the various
chimeric plasmids are shown in Fig. 2. pHK5A, pHK18A, and pHK12A were
derived from plasmid A by replacing MHV sequences containing the predicted
SL1, SL2, and SL3 structures with their predicted SCoV counterparts, respec-
tively (Table 2). pHK4A was generated from pHK0A by replacing SCoV SL1,
SL2, and SL3 with their MHV counterparts (Table 2). pHK8A was generated
using “no see’m” technology that replaced MHV SL4 with its SCoV counterpart
(Table 2) (37). To replace MHV SL4 with SCoV SL4, a 5 DNA fragment
spanning MHV SL1, SL2, and TRS and SCoV SL4 was amplified from pHK4A
using primers containing MluI (sense) and BsmBI (antisense) restriction sites
(MluI-T7-F and SL4-only-BsmBI-R). A 3 DNA fragment spanning the se-
quence between the MHV SL4 and a BamHI site in ORF1a was amplified from
plasmid A using primers containing BsmBI (sense) and BamHI (antisense) sites
(7059 antisense oligonucleotide 8 and SL4-only-BsmBI-R). These 5 and 3
fragments were cloned into the pGEM-T easy vector, subsequently retrieved by
double digestion of MluI and BsmBI or BamHI and BsmBI, and ligated into
MluI and BamHI sites in plasmid A to eventually construct pHK8A. pHK11A
was also generated using “no see’m” technology that replaced the MHV se-
quence between SL4 and the ORF1a start codon with its SCoV counterpart
(Table 2). A 5 DNA fragment spanning MHV SL1, SL2, TRS, and SL4 was
amplified from plasmid A using primers containing MluI (sense primer MluI-
T7-F) and BsmBI (antisense primer b/w SL4-AUG-BsmBI-R) sites. A 3 DNA
fragment spanning both (i) SCoV sequences between SL4 and the MHV ORF1a
start codon and (ii) MHV sequences between the MHV ORF1a start codon and
a BamHI site in MHV ORF1a was amplified from pHK4A using primers con-
taining BsmBI (sense primer b/w SL4-AUG-BsmBI-F) and BamHI (7059 anti-
TABLE 2. Plasmids used in this study
Plasmid or 3UTR
chimera Characteristics Sequence of 5 region
a
pHK1A pHK0A replaced SCoV TRS core sequence (SCoV 67–72)b with MHV
TRS core sequence (MHV 65–71)c
SCoV 1–66/MHV 65–71/SCoV 73–264
pHK4A pHK0A replaced SCoV SL1, SL2, and SL3 (SCoV 1–72) with their
MHV counterpart (MHV 1–68)
MHV 1–68/SCoV 73–264
pHK5A Plasmid A replaced MHV 5UTR SL1 (MHV 1–40) with SCoV
5UTR SL1 (SCoV 1–35)
SCoV 1–35/MHV 41–209
pHK8A Plasmid A replaced MHV 5UTR SL4 (MHV 67–139) with SCoV
5UTR SL4 (SCoV 73–130)
MHV 1–66/SCoV 73–130/MHV 140–209
pHK11A Plasmid A replaced MHV sequence (MHV 140–209) between SL4 and
start codon of ORF1 with its SCoV counterpart (SCoV 136–264)
MHV 1–139/SCoV 136–264
pHK12A Plasmid A replaced MHV TRS core and flanking sequence (MHV
59–73) with SCoV 5UTR SL3 (SCoV 58–72)
MHV 1–58/SCoV 58–72/MHV 74–209
pHK18A Plasmid A replaced MHV 5UTR SL2 (MHV 42–56) with SCoV
5UTR SL2 (SCoV 42–57)
MHV 1–41/SCoV 42–57/MHV 57–209
pLP0F Plasmid F containing a frameshift mutation at nt 398 of nsp12 (RdRp)
p0A-1 pGEM-T vector carrying SCoV 5UTR with BsmBI site at 5
and 3 terminals
p0A-2 PCR-XL-TOPO carrying BamHI fragment of plasmid A
p0A-3 p0A-2 deleted MHV 5UTR by inverse PCR with primers containing
BsmBI sites
p7077 p0A-3 ligated with BsmBI fragment from p0A-1
pHK0A Plasmid A replaced with the BamHI fragment of p7077 by restriction
fragment exchange, which ultimately replaced MHV 5UTR (MHV
1–209) with SCoV 5UTR (SCoV 1–264)
SCoV 1–264
pB36 T7 transcription vector encoding an MHV A59 DI RNA consisting of
467 nt of the 5 end of the genome connected in frame, via a 48-nt
linker, to the entire N gene and 3UTR, followed by a poly(A) tail
of approximately 115 residuesd
p0G-1 pGEM-T vector carrying SCoV 3UTR and 15 nt of poly(A) tail
p0G-2 pB36 deleted MHV 3UTR by inverse PCR with primers containing
BsmBI sites
p0G-3 p0G-2 ligated with BsmBI fragment from p0G-1
pMF1G G plasmid replaced with the NheI and PacI fragments of p0G-3 by
restriction fragment exchange, which ultimately replaced MHV
3UTR (MHV 31034–31357) with SCoV 3UTR (SCoV
29389–29751)
SCoV 29389–29751
a The SCoV or MHV origin of sequences in the chimeric portion of the plasmids are given.
b Indicates SCoV sequence relative to the SCoV genome reported under GenBank accession no. AY278741 (27).
c Indicates MHV sequence relative to the MHV genome reported under GenBank accession no. NC_001846 (39).
d See reference 14.
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sense oligonucleotide 8) sites. These 5 and 3 fragments were cloned into the
pGEM-T easy vector, subsequently retrieved by double digestion of MluI and
BsmBI or BamHI and BsmBI, and ligated into MluI and BamHI sites in plasmid
A to eventually construct pHK11A. A frameshift mutation in ORF1b was created
by digesting plasmid F (nt 398) with MunI, filling in the 4-base overhang with
Klenow fragment, and religating the plasmid. This produced a plasmid called
pLP0F, containing a frameshift mutation that should knock out the expression of
functional NSP12 (RdRp) to NSP16 (Table 2).
Plaque purification, RT-PCR, and sequencing. Mutant viruses were subjected
to one round of plaque purification and were expanded once in DBT cells. The
sequences of recovered viruses were confirmed by RT-PCR of the 5UTR and
3UTR, followed by direct sequencing of the amplified products.
Growth curves. DBT cells were grown in 96-well plates, and replicate wells
were infected at a multiplicity of infection (MOI) of 3 with mutant or wild-type
MHV-A59 1000 virus. After washing away the inocula, cultures were incubated
until 0, 4, 8, 12, 16, and 24 h postinfection, when they were frozen at 70°C.
Triplicate samples were obtained at all time points. Virus production was quan-
titated by plaque assay on L2 cell monolayers.
Metabolic labeling. DBT cells (2.25  105 cells/well) were seeded into 24-well
plates and incubated at 37°C for 15 h to reach approximately 2.5  105 cells. The
DBT cells were infected at an MOI of 1 (2.5  105 PFU) or mock infected,
further incubated for 6 h, washed two times with phosphate-free DMEM, fed
with DMEM supplemented with 2% dialyzed calf serum and 10 g/ml of acti-
nomycin D, and incubated at 37°C for 15 min. At the end of 15 min, the medium
was replaced with phosphate-free medium containing 10 g/ml actinomycin D,
2% dialyzed serum, and 200 Ci/ml 32PO4 and incubated at 37°C for 5.5 h, by
which time 90% of the cells infected with wild-type MHV-A59 1000 had formed
syncytial giant cells. The labeled cultures were washed twice with cold phosphate-
buffered saline, and RNA was extracted using an RNeasy Mini kit (QIAGEN).
The amount of RNA in each sample was measured using the RediPlate 96
RiboGreen RNA quantitation kit (Invitrogen). Equal amounts of radiolabeled
viral RNA (10 g) were denatured in formaldehyde gel loading buffer containing
ethidium bromide (20 g/ml) at 65°C for 15 min and then electrophoresed in a
1% formaldehyde–agarose gel at 100 V for 5 h. Following electrophoresis, the gel
was illuminated with UV light, the image was captured with a FluorChem 8900
(AlphaInotech) imaging system, and the relative amount of 18S rRNA bands was
determined by densitometry. The gel was soaked in 70% methanol for 30 min,
dried over a vacuum, and exposed to X-ray film. The amount of the individual
subgenomic RNAs (sgRNAs) relative to genome-sized RNA (gRNA) and the
relative amount of radiolabeled RNA in each sample were determined by ex-
posing the dried gel to a Molecular Dynamics PhosphorImager equipped with
Storm 8.2 software. The amount of 18S rRNA in each sample was used to
normalize the PhosphorImager signals to account for small differences in the
total amounts of RNA loaded per sample.
Detection of gRNA and sgmRNA. A series of nested RT-PCR assays was
performed to analyze RNAs produced by nonviable chimeric genomes. Chimeric
genomes or wild-type MHV-A59 1000 RNA was electroporated into BHK-R
cells, and total RNAs were extracted at 8 and 24 h postelectroporation (p.e.). In
order to determine if the input RNAs, plus any replicated genome RNA, were
present in the electroporated cells, the extracted RNAs were primed for reverse
transcription by 7059 antisense oligonucleotide 8, followed by PCR using SCoV
or MHV 5 1-20 () primers and 7059 () oligonucleotide 8. The RNA species
present in cells electroporated with these chimeric genomes were characterized
using nested RT-PCR methods described previously (16, 17, 21). For analyzing
the synthesis of minus-sense gRNA by the chimeric viruses, the extracted RNAs
were primed for reverse transcription by oligonucleotide A59() 14639-14658
and followed by the first PCR using oligonucleotide A59() 14639-14658 and
oligonucleotide A59() 16596-16577. The resultant PCR products were further
amplified by nested PCR using oligonucleotide A59() 16038-16059 and oligo-
nucleotide A59() 16596-16577. Parallel reactions (without RT) in which re-
verse transcriptase was omitted from the cDNA step were always performed to
ensure that the PCRs did not detect residual DNA transcription templates that
entered the cells during electroporation. To detect plus- or minus-sense sub-
genomic mRNA7 (sgmRNA7), the extracted RNAs were primed for reverse
transcription by antisense primer 7065 to detect minus-sense sgmRNA7 and by
SCoV (GenBank accession no. AY278741) or MHV 5 1-20 sense primers to
detect minus-sense sgmRNA7, respectively. The resultant cDNAs were used as
templates for the first PCR using SCoV or MHV 5 1-20 sense primers and the
7065 antisense primer. The first PCR products were further amplified by nested
PCR using SCoV or MHV 5 1-20 sense primers and the N antisense primer, and
the nested PCR products were displayed by gel electrophoresis.
RESULTS
Comparison of secondary structures for the 5-most 140 nt
of the 5UTRs of MHV and SCoV. Consensus secondary struc-
tural models for the 5-most 140 nt of the 5UTR from MHV
and SCoV were developed using the secondary structure pre-
diction algorithms ViennaRNA 1.5 (12) and mfold 3.1 (40) that
were informed by a multiple sequence alignment of nine CoV
5UTRs (MHV [GenBank accession no. NC_001846], SCoV
[accession no. NC_004718], BCoV [accession no. NC_003045],
HCoV-OC43 [accession no. NC_005147], HCoV-HKU1 [ac-
cession no. NC_006577], HCoV-NL63 [accession no.
NC_005831], HCoV-229E _accession no. NC_002645], trans-
missible gastroenteritis virus (TGEV) [accession no.
NC_002306], and infectious bronchitis virus (IBV) [accession
no. NC_001451]) and examined for potential sequence co-
variations that might support the secondary structure predic-
tion. The predicted secondary structural models from nine
CoV genomes are strikingly similar and are characterized by
three major putative helical stem-loops, named SL1, SL2, and
SL4 (Fig. 1). The consensus model is anchored by SL2, which
contains a highly conserved and previously unrecognized (C/
U)UUG(U/C) U-turn containing a pentaloop (4) sequence
stacked on a 5-bp stem of variable composition. While the
predicted SL2 stem differs in sequence from virus to virus (Fig.
1B), SL2 is the most conserved structural element in the MHV
and SCoV 5UTR sequences (53.4% overall sequence identity
in the first 140 nt) (21). Provided that the stem of SL2 is forced
to be base paired, the consensus model is independent of the
secondary structure prediction algorithm used (both mfold 3.1
and PKNOTS were tested) (26, 40). The existence of this base
pairing is supported by covariation in the stem sequences (Fig.
1B; see Fig. S1 in the supplemental material). Extending these
predictions to encompass the entire MHV and SCoV 5UTRs
also predicted the structures SL1 to SL4 (data not shown).
In contrast to SL2, the predicted structures of SL1 and SL4
differ in detail between MHV and SCoV. MHV SL1 has a
longer hairpin loop and has two consecutive pyrimidine-pyri-
midine mismatches in the stem that are not predicted to be
present in SCoV SL1. The predicted MHV SL4 stem contains
two internal loops not present in the SCoV SL4 stem. The
SCoV 140-nt sequence is predicted to contain a fourth putative
stem-loop, named SL3, spanning the SCoV TRS 5-flanking
sequence (5FS) and CSs. Consistent with our data, van den
Born et al. previously predicted that the SCoV TRS CS was
contained in the loop portion of a stem-loop structure (33).
The counterpart MHV TRS sequence is located between SL2
and SL4 but is predicted to be single stranded or weakly folded
at 25°C. The predicted single-stranded region between SCoV
SL1 and SL2 was longer (8 nt) than the corresponding region
in MHV (1 nt). The SCoV sequence region between the pu-
tative SL4 and the start codon of nsp1 (nt 131 to 264) is 65 nt
longer than its MHV counterpart (nt 141 to 209), and no
significant similarity was found between the two RNA se-
quences in this region. ViennaRNA 1.5 predicted that this
SCoV sequence region forms four stem-loop structures but
that its MHV counterpart forms just two stem-loop structures.
The SCoV 5UTR cannot functionally replace the MHV
5UTR. An examination of the sequences contained in the
SCoV 5UTR SL3 revealed that in addition to the SCoV TRS
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CS (ACGAAC [nt 67 to 72]), this structure also contained an
overlapping MHV TRS CS (UCUAAAC [nt 62 to 67]) (Fig.
1). This led us to investigate whether the SCoV 5UTR could
functionally replace its MHV counterpart. In the reverse ge-
netic system for MHV-A59 described previously by Yount et
al. (37), plasmid A contains the 5UTR plus an additional
4,672 nt of the ORF1a coding sequence. As described in Ma-
terials and Methods, we generated a modified plasmid A in
which the entire MHV 5UTR was precisely replaced by the
SCoV 5UTR (pHK0A) (Table 2 and Fig. 2). The chimeric
cDNA contained in this plasmid was excised and ligated to
cloned cDNAs B to G (37) and transcribed in vitro to generate
chimeric MHV-A59 genome RNAs in which the SCoV 5UTR
had replaced the corresponding MHV sequences (MHV/
SCoV-5UTR). Three attempts to recover infectious virus af-
ter electroporation into MHV-permissive BHK-R cells were
unsuccessful, including one attempt in which replicate electro-
porated cultures were incubated at 34°C and 40°C. To confirm
that these chimeric genomes were nonviable, the electropo-
rated cell cultures were frozen at 70°C to release cell-asso-
ciated virus and blind passaged three times on DBT cells with-
out developing cytopathic effects. Lysates from the third blind
passage were subjected to plaque assay using L2 cells. No
plaques were observed in all three independent experiments.
Thus, we concluded that the MHV/SCoV-5 UTR chimeric
genome was nonviable (Fig. 3).
We next determined if a modified MHV/SCoV-5UTR chi-
mera in which the SCoV TRS CS was replaced by the MHV
TRS CS (MHV/SCoV-5UTR/MHV-TRS) (Fig. 2) was viable.
Chimeric genomes were transcribed from ligated cDNAs and
electroporated into BHK-R cells, and virus isolation from
these cultures was attempted as described above. After three
unsuccessful attempts to recover recombinant virus, we con-
cluded that this chimeric genome was also not viable (Fig. 3).
SCoV 5UTR SL1, SL2, and SL4 were functionally ex-
changeable with their MHV counterparts. We next determined
whether individual predicted stem-loop structures in the SCoV
5UTR could functionally replace their MHV counterparts.
The following MHV/SCoV chimeric genomes were generated
as described in Materials and Methods (Table 2 and Fig. 2): (i)
A59/SCoV-SL1 (MHV SL1 was replaced with SCoV SL1 using
pHK5A), (ii) A59/SCoV-SL2 (MHV SL2 was replaced with
SCoV SL2 using pHK18A), (iii) A59/SCoV-SL3 (MHV TRS
CS and 8 nt of the 5FS were replaced with SCoV SL3 using
pHK12A), (iv) A59/SCoV-SL4 (MHV SL4 was replaced with
SCoV SL4 using pHK8A), (v) A59/SCoV-b/w SL4&AUG (the
FIG. 3. Morphologies of plaques formed by MHV and SCoV chimeric genomes. Cultures of BHK-R cells were electroporated with MHV/
SCoV chimeric or MHV-A59 full-length transcripts and seeded onto DBT cells in 75-cm2 flasks. If a genome produced viable virus progeny, the
progeny was plaque purified and amplified once in DBT cells. The plaques shown are wild-type MHV-A59 1000 virus (A), MHV/SCoV-SL1 (E),
MHV/SCoV-SL2 (F), MHV/SCoV-SL4 (H), and MHV/SCoV-3UTR (C) chimeric viruses. Nonviable chimeric genomes did not form any visible
plaque (B, D, G, I, J, and K).
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MHV sequence region between SL4 and the start codon
[AUG] of nsp1 was replaced with its SCoV counterpart using
pHK11A), and (vi) MHV/SCoV-3UTR (MHV 3UTR was
replaced with the SCoV 3UTR using pMF1G). As a negative
control, A59/nsp12-FS was generated using pLP1F, a plasmid
that contained a cDNA construct harboring a frameshift mu-
tation in the RdRp domain (nsp12) that should abrogate the
translation of downstream nsp13 to nsp16. Cultures electropo-
rated with A59/SCoV-SL1, A59/SCoV-SL2, A59/SCoV-SL4,
and A59/SCoV-3UTR chimeric genomes developed a CPE
after 24 to 48 h. Viable virus was recovered from the medium,
plaque purified, and expanded in DBT cells (Fig. 3). Sequenc-
ing analyses confirmed that there were no additional muta-
tions in the 3UTRs and 5UTRs of the recovered viruses.
The cultures electroporated with A59/SCoV-SL3 and A59/
SCoV-b/w SL4&AUG chimeric genomes and the A59/
nsp12-FS mutant genome failed to develop CPE. To confirm
that these viral genomes were nonviable, the electroporated
cell cultures were frozen at 70°C to release cell-associated
virus and blind passaged three times on DBT cells. Lysates
from the third blind passage were subjected to plaque assay
using L2 cells. No plaques were observed in three indepen-
dent experiments for each of these viruses. Thus, the A59/
SCoV-SL3 and A59/SCoV-b/w SL4&AUG chimeric ge-
nomes and the A59/nsp12-FS mutant genome were judged
to be nonviable (Fig. 3).
Phenotypic properties of the MHV/SCoV chimeric viruses.
Plaque size and growth kinetics of the recovered chimeric
FIG. 4. Average plaque sizes of wild-type MHV-A59 1000 and
MHV/SCoV-SL1, MHV/SCoV-SL2, MHV/SCoV-SL4, and MHV/
SCoV-3UTR chimeric viruses. The middle bar in each column indi-
cates the mean plaque size of the corresponding virus.
FIG. 5. One-step growth kinetics for wild-type MHV-A59 1000 and MHV/SCoV-SL1 (A), MHV/SCoV-SL2 (B), MHV/SCoV-SL4 (C), and
MHV/SCoV-3UTR (D) chimeric viruses. Triplicate DBT cell cultures in a 96-well plate were infected at an MOI of 3 and harvested at the
designated hours postinfection, and viral titers were determined by plaque assay.
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viruses were compared to those of parental MHV-A59 1000.
As shown in Fig. 3, the MHV/SCoV chimeric viruses made
smaller plaques than the parental MHV-A59 1000 virus. Av-
erage plaque sizes of A59/SCoV-SL1, A59/SCoV-SL2, A59/
SCoV-SL4, and A59/SCoV-3UTR chimeric viruses were 1.2
(0.07), 1.8 (0.09), 1.1 (0.04), and 1.4 (0.07) mm in
diameter, respectively (Fig. 4). These sizes corresponded to
39% (P 	 0.05) to 64% (P 	 0.05) of the average plaque size
of MHV-A59 1000, which is 2.8 (0.07) mm in diameter.
A59/SCoV-SL1, A59/SCoV-SL4, and A59/SCoV-3UTR chi-
meric viruses grew to lower titers, had significantly delayed
growth kinetics relative to those of MHV-A59 1000, and
achieved maximal titers 15- to 40-fold less than those achieved
by the parental MHV-A59 1000 virus (Fig. 5). However, A59/
SCoV-SL2 grew almost as well as the parental virus, achieving
a titer only fourfold lower than that of MHV-A59 1000 (Fig. 5).
To determine whether the altered growth phenotypes of the
chimeric 5UTR viruses are a result of deficits in genome
replication or subgenomic RNA synthesis, virus-specific RNAs
were metabolically radiolabeled and analyzed by gel electro-
phoresis (Fig. 6). DBT cells were either mock infected, in-
fected with MHV-A59 1000 (WT), or infected with MHV/
SCoV chimeric viruses. Starting at 5 h postinfection, MHV-
specific RNAs were labeled for 5.5 h with 32PO4 in the
presence of actinomycin D. After labeling, total viral and cel-
lular RNAs were extracted from cell lysates and quantitated,
and equal amounts of RNA were electrophoresed in formal-
dehyde-agarose gels. Total RNAs were visualized by ethidium
bromide staining, and labeled MHV-specific RNAs were visu-
alized by autoradiography. The amount of each MHV-specific
RNA as well as the total amount of labeled virus-specific RNA
in each sample were quantitated with a PhosphorImager (Fig.
6). All seven species of MHV-specific RNA were detected in
cells infected with the MHV/SCoV chimeric viruses and MHV-
A59 1000. The total amount of radiolabeled MHV-specific
RNA (gRNA [genome] through sgmRNA7) in MHV/SCoV-
SL2-infected cells was 92% of that detected in MHV-A59
1000-infected cells, a result that correlates with the relatively
modest impairment of viral replication that we observed for
this chimera. However, the amount of virus-specific RNA syn-
thesis in cells infected with MHV/SCoV-SL1 (32% relative to
WT), MHV/SCoV-SL4 (46%), and MHV/SCoV-3UTR
(42%) was significantly lower than that observed in cells in-
fected with MHV-A59 1000 (Fig. 6). This decrease in RNA
synthesis correlates with the decrease in replication efficiency
that we observed in one-step growth curves (Fig. 5). The rel-
ative molar ratios of gRNA to sgmRNAs present in cells in-
fected with MHV/SCoV chimeric viruses were generally simi-
lar to those found in cells infected with the wild type, with
some exceptions for individual sgmRNAs (Table 3). The larg-
est difference observed was an almost threefold increase in the
relative molar ratio of sgmRNA2 to genome RNA in cells
infected with A59/SCoV-SL1.
Nonviable MHV/SCoV chimeric genomes have defects in
RNA synthesis. We examined the stage at which RNA repli-
cation or transcription of the nonviable chimeric genomes was
blocked using a series of nested RT-PCR assays (summarized
in Table 4). Replicate cultures of BHK-R cells were separately
electroporated with in vitro-synthesized genomic RNAs corre-
sponding to A59/SCoV-5UTR, A59/SCoV-5UTR/MHV-
TRS, and A59/SCoV-SL3 chimeric genomes; the A59/
nsp12-FS mutant genome (a frameshift mutant expected to
abrogate the expression of proteins required for RNA replica-
tion); and parental MHV-A59 1000. RNAs were extracted
from the electroporated cultures at 8 and 24 h p.e. As ex-
pected, nested RT-PCR analyses of RNA extracted from cells
electroporated with the A59/nsp12-FS (Fig. 7B, lanes 1 and 2)
mutant genome failed to detect minus-sense gRNA at either
time point, whereas this RNA species was readily detected at
both time points in cells electroporated with the MHV-A59
FIG. 6. RNA synthesis in cells infected with MHV/SCoV chimeric
viruses. Cells were either mock infected or infected with MHV/SCoV-
SL1, MHV/SCoV-SL2, MHV/SCoV-SL4, MHV/SCoV-3UTR, or
MHV-A59 1000, and viral RNAs were metabolically labeled as de-
scribed in Materials and Methods. The labeled viral RNAs were re-
solved by formaldehyde agarose gel electrophoresis and visualized by
autoradiography. Brightness and contrast have been adjusted to en-
hance the visibility of the bands of the MHV/SCoV chimeric viruses
using Adobe Photoshop 6.0. Arrows indicate the positions of bands of
virus-specific RNA1 to RNA7.
TABLE 3. Relative molar amounts of virus-specific RNAs synthesized
in cells infected with MHV/SCoV chimeric viruses
RNA
species
Relative molar amt
MHV-A59
1000
A59/SCoV-
SL1
A59/SCoV-
SL2
A59/SCoV-
SL4
A59/SCoV-
3UTR
RNA1 1.00 1.00 1.00 1.00 1.00
sgmRNA2 1.12 3.01 1.32 1.69 1.47
sgmRNA3 1.57 2.82 1.68 1.75 1.63
sgmRNA4 6.83 7.33 7.93 7.38 7.52
sgmRNA5 3.41 4.42 3.69 4.41 3.87
sgmRNA6 10.49 7.40 7.21 6.02 9.52
sgmRNA7 38.95 31.97 33.59 51.47 45.36
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1000 genome (Fig. 7B, lanes 9 and 10). Minus-sense gRNA was
undetectable in cells electroporated with the A59/SCoV-
5UTR chimera (Fig. 7B, lanes 3 and 4) but was detectable in
cells electroporated with the A59/SCoV-5UTR/MHV-TRS
and A59/SCoV-SL3 chimeras (Fig. 7B, lanes 5 to 8). Assays to
detect plus- or minus-sense sgmRNA7s were similarly negative
with RNAs obtained from cells electroporated with the A59/
SCoV-5UTR chimera (Fig. 7D, lanes 5 to 8) or the A59/
nsp12-FS mutant (Fig. 7D, lanes 1 to 4), indicating that these
genomes had global defects in RNA synthesis. The nested
RT-PCR assay showed that at 24 h p.e., the A59/SCoV-
5UTR/MHV-TRS (Fig. 7D, lanes 9 to 12) and A59/SCoV-
SL3 (Fig. 7D, lanes 13 to 16) chimeric genomes directed the
synthesis of minus-sense gRNA at levels that appeared to be
roughly similar to those observed in cells electroporated with
wild-type MHV-A59 1000. Semiquantitative nested RT-PCR
assays with serially diluted RNA templates confirmed that the
cultures electroporated with the A59/SCoV-5UTR/MHV-
TRS and A59/SCoV-SL3 genomes contained amounts of mi-
nus-sense gRNA that were roughly equivalent to those of cells
electroporated with MHV-A59 (data not shown). However,
neither minus- nor plus-sense sgmRNA7 could be detected in
cells electroporated with these two chimeric genomes (Fig. 7D,
lanes 9 to 16), whereas these RNAs were easily detectable in
cells electroporated with the parental MHV-A59 1000 genome
(Fig. 7D, lanes 17 to 20).
DISCUSSION
The reverse genetic studies described above investigated the
possibility that the SCoV 5UTR, or selected regions of the
5UTR, can functionally replace MHV counterparts. These
studies were guided by a phylogenetic analysis that places both
SCoV and MHV in the group 2 coronaviruses (30) and on a
novel secondary structure model that predicts similar second-
ary structures for all of the group 2 coronaviruses in the first
140 nt of their 5UTRs (17, 21). This model is supported by
NMR, thermal denaturation, and reverse genetic studies that
provide support for the presence and functional importance of
the highly conserved, but previously overlooked, predicted SL2
stem-loop containing a U-turn motif (Liu et al., unpublished)
(21). NMR studies and reverse genetic studies introducing
mutations into putative SL1 indicate that this structure is also
functionally important for MHV replication (H. Kang et al.,
unpublished results). Although this model differs from a prior
model of the BCoV 5UTR, another group 2 coronavirus (5),
in several key respects, both models predict a stem-loop struc-
ture that is part of SL4 in our model (nt 97 to 117) and that was
previously designated stem-loop III in the BCoV model (24).
The integrity of the stem portion of stem-loop III is required
for BCoV DI RNA replication (24). Taken together, these
results support the designation of SL1, SL2, and SL4 structures
as putative cis-acting elements for MHV genome replication.
Our model differs from prior models of coronavirus 5UTRs
in one important respect. The BCoV model referenced above
predicts that the leader TRS CS will be in the loop portion of
stem-loop II (5). Similarly, van den Born et al. (33) predicted
that in addition to BCoV, other coronaviruses, including
MHV, will fold such that the TRS is in the loop portion of a
stem-loop structure. In our model, the MHV TRS is unstruc-
tured or is contained in a weakly stable stem-loop, SL3 (Fig. 1).
mfold 3.1 (http://www.bioinfo.rpi.edu/applications/mfold/old
/rna/form1.cgi) generates four secondary structures for the
MHV 5 140 nt. These four structures have free energies of
between 33.6 kcal/mol and 32.3 kcal/mol. Two of the four
structures (with free energies of 33.4 and 32.8 kcal/mol)
position the TRS sequence in the loop portion of a stem-loop.
Our secondary structure model corresponds to an mfold struc-
ture with a free energy of 32.3 kcal/mol, only slightly less
stable than the two structures putting the TRS into a hairpin
loop. However, if folding is constrained to take into account
the covariation that strongly predicts the existence of SL2 (Fig.
1B), our model is the most stable structure generated by mfold.
None of the data rule out the possibility that the secondary
structures that we propose for the 5UTR are in equilibrium
with additional structures similar to those proposed previously
by van den Born et al. (33) and Chang et al. (5).
We show here that the SCoV 5UTR cannot functionally
replace the MHV 5UTR, but we confirm data from a previous
study where functional replacement of the MHV 3UTR by the
SCoV 3UTR was observed in a recombinant virus generated
by targeted RNA recombination (10). Although there is little
sequence identity between the MHV and SCoV 3UTRs, both
3UTRs can be folded into similar secondary structures that
contain stem-loop and pseudoknot elements characteristic of
group 2 coronaviruses (10). However, the full MHV and SCoV
5UTRs are significantly different in terms of sequences and
predicted secondary structures. The SCoV 5UTR sequence is
55 nt longer than the MHV 5UTR. Relative to the MHV
counterpart, the region downstream of the putative SL4 in the
SCoV 5UTR was expanded to 65 nt in our secondary structure
model. This region of the SCoV 5UTR from 131 to 264 nt is
predicted to fold quite differently than the corresponding re-
gion of the MHV 5UTR (nt 141 to 209) and contains two
additional stem-loops relative to its MHV counterpart (data
not shown). Considering the 5-most 140-nt sequences of the
MHV and SCoV 5UTRs, which are predicted to fold quite
similarly, the SCoV sequence region is predicted to contain an
additional stem-loop, called SL3, that is absent from its MHV
counterpart. Any or all of these differences in the sequences
and secondary structures might contribute to the nonexchange-
ability of the SCoV 5UTR for its MHV counterpart.
In the reverse genetic studies reported here, we demonstrate
that sequences containing the predicted SCoV SL1, SL2, and
TABLE 4. Characterization of RNA species produced by nonviable
MHV/SCoV chimeric genomes
Genome
Detection of:
Minus-strand
gRNAa
Minus-strand
sgmRNA7a
Positive-strand
sgmRNA7a
MHV-A59 1000 Yes Yes Yes
A59/nsp12-FS No No No
MHV/SCoV-5UTR No No No
MHV/SCoV-5UTR/
MHV-TRS
Yes No No
MHV/SCoV-SL3 Yes No No
A59/SCoV-b/w SL4&AUG Yes No No
a Indicates whether the RNA species was detected in cells electroporated with
wild-type or chimeric genomes.
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FIG. 7. Nested RT-PCR assays for minus-sense gRNA and sgmRNA7. (A) Schematic drawing of the assay used to detect minus-sense ()
gRNA and the relative locations of the primers within the genome. (B) RT-PCR of RNAs extracted from MHV-A59 1000 (WT) and nonviable
MHV/SCoV chimeric genome-electroporated cells at 8 and 24 h p.e. The arrow indicates the specifically amplified fragment from minus-sense
gRNA. W/RT and W/O RT indicate products of nested RT-PCR (left) and the corresponding no-RT control reactions (right), respectively.
(C) Schematic representation of the RT-nested PCR strategy and primers used to detect minus- and plus-sense sgmRNA7s. (D) Representative
nested RT-PCR for minus- and plus-sense sgmRNA7s. The arrow indicates the specifically amplified sgmRNA7 fragment. The relative sizes of the
leader sequences in sgmRNA7 and the body of sgmRNA7 are not to scale. The sizes of the marker DNAs in base pairs are shown to the right of
electropherograms. The amplified products corresponding to minus-sense sgmRNA7 are shown in lanes 1, 3, 5, 7, 9, 11, 13, 15, 17, and 19. Products
corresponding to plus-sense sgmRNA7 are shown in lanes 2, 4, 6, 8, 10, 12, 14, 16, 18, and 20. The position of each primer in the MHV-A59 genome
(GenBank accession no. NC_001846) is given in parentheses as part of the primer name. Primer sequences are listed in Table 1. A 1-kbp ladder
was used as a molecular size marker.
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SL4 structures can functionally replace their MHV counter-
parts. The predicted MHV SL1 structure contains two consec-
utive noncanonical pyrimidine-pyrimidine base pairs in the
stem that are not apparent in the predicted SCoV SL1 struc-
ture. The SCoV SL1 substitution produced spacing with 2 nt
between the predicted MHV SL1 and SL2. The predicted
MHV and SCoV SL2 structures both contain identical U-turn
motifs in the loop (CUUGU). This U-turn motif is associated
with a sharp turn in the phosphate backbone between U0 and
N1 (11). Moreover, both stems of the MHV and SCoV SL2s
were identical except for one base pair at the base of the stem.
As the MHV and SCoV SL4s contained potential homologs of
the BCoV stem-loop III (24), both ViennaRNA 1.5 and Zuker
mfold algorithms predict approximately the same secondary
structure in the 5-most 80- to 140-nt sequence regions of
MHV, SCoV, and BCoV, with SL4 and stem-loop III struc-
tures conserved in all of these viruses and, in fact, in all coro-
naviruses (24). Overall, these slight differences in the predicted
secondary structural configurations of MHV and SCoV stem-
loops did not affect viral viability, but they may have contrib-
uted to the reduced viral replication efficiency.
In contrast, the MHV sequence region spanning the TRS
CS, 6 nt of 5FS, and 2 nt of 3FS could not be functionally
replaced by its SCoV counterpart, SL3 (chimeric genome A59/
SCoV-SL3). Although the SCoV sequence region contains
both the MHV and SCoV TRS CSs, the ViennaRNA 1.5
algorithm predicts that the SCoV sequence TRS region forms
a stem-loop structure (SL3), while its MHV counterpart
adopts an unpaired structure or one that is predicted to be
weakly folded at 25°C. NMR and thermal denaturation exper-
iments using an SCoV RNA encompassing SL2 and SL3 (nt 42
to 72) support the presence of a double-hairpin structure in
SCoV (Li and Giedroc, unpublished). This structural differ-
ence might contribute to the functional nonexchangeability of
TRS sequence regions. Similarly, the SCoV sequence region
between SL4 and the start codon of nsp1 is also different in
both sequence and secondary structure from its MHV coun-
terpart, which might consequently contribute to the nonviabil-
ity of the A59/SCoV-b/w SL4&AUG chimeric genome.
An attempt to generate a viable A59/SCoV-5UTR chimeric
genome led to the generation of the A59/SCoV-5UTR/MHV-
TRS chimeric genome, a construct that contains the correct
MHV leader TRS. However, the resultant chimeric genome
was also nonviable and failed to produce minus- or plus-sense
sgmRNA7s. Based on these results, the inability of the SCoV
5UTR to replace the MHV 5UTR was not a single conse-
quence of a mismatch of the leader TRS with downstream
intergenic TRS sequences. Thus, other differences in se-
quences or secondary structures, especially the difference in
sequences between SL4 and the start codon of nsp1, likely
contribute to the observed defects in genome replication and
subgenomic RNA synthesis.
Minus-sense gRNA was synthesized in the cells electropo-
rated with A59/SCoV-5UTR/MHV-TRS and A59/SCoV-SL3
chimeric genomes but not in cells electroporated with the
A59/SCoV-5UTR chimera. It was impossible to determine if
electroporated cultures containing minus-sense gRNA but not
sgmRNA also synthesized a plus-sense genome. Input genome
RNA persisted at easily detectable levels in cells electropo-
rated with a genome unable to direct the synthesis of RNA
replicase genes (A59/nsp12-FS, a frameshift mutant expected
to abrogate the expression of proteins required for RNA rep-
lication) until 24 h p.e., a time when cell fusion was apparent
in cultures electroporated with MHV-A59 1000 (data not
shown). Real-time RT-PCR assays could not detect a quanti-
tative difference in the amounts of plus-sense gRNAs present
in cells electroporated with MHV-A59 1000, A59/nsp12-FS,
and the nonviable chimeric genomes at 8 h p.e. At 24 h p.e., the
amount of plus-sense gRNA present in cells electroporated
with MHV-A59 1000 was significantly greater than that present
in cells electroporated with A59/nsp12-FS, A59/SCoV-5UTR/
MHV-TRS, or A59/SCoV-SL3 genomes (data not shown). We
concluded that the genome RNAs detected in cells electropo-
rated with nonviable chimeras represented electroporated
RNA genomes rather than replicated molecules, since they
were found in amounts similar to those for the A59/nsp12-FS
genome at 8 and 24 h p.e. Thus, in the absence of subgenomic
RNA synthesis and cell fusion, it was impossible to determine
if plus-sense gRNA synthesis was directed by the nonviable
chimeric genomes, because the persistence of the electropo-
rated RNAs would obscure low levels of genome replication.
The nonviable chimeric genomes (A59/SCoV-5UTR, A59/
SCoV-5UTR/MHV-TRS, and A59/SCoV-SL3) produced nei-
ther minus- nor plus-sense sgmRNA7. Thus, the replacement
of the entire MHV 5UTR with the complete SCoV 5UTR
resulted in a genome that failed to synthesize any viral RNA
species. Replacement of the SCoV TRS CS with the MHV
TRS CS plus 5 nt of 5FS and 4 nt of 3FS in the SCoV 5UTR
background allowed the synthesis of minus-sense gRNA but
not sgmRNA7s of either sense. In addition, the insertion of the
SCoV region spanning the TRS CS and 5FS 9 nt in place of
the corresponding MHV sequences in the MHV 5UTR back-
ground did not disrupt the synthesis of minus-sense gRNA. A
possible explanation for the synthesis of this RNA species in
cells electroporated with these nonviable chimeric genomes
can be found in the three-step working model for coronavirus
mRNA transcription described previously (41), consisting of
5-to-3 complex formation, base-pairing scanning, and tem-
plate switching. The A59/SCoV-5UTR chimeric genome
might be blocked in the first step, 5-to-3 complex formation.
Both the MHV N protein and the polypyrimidine tract binding
(PTB) protein bind to the MHV leader TRS region (20, 35).
These proteins might not efficiently bind to the leader MHV
TRS CS in the SCoV 5UTR background, or poor comple-
mentarity of sequences flanking the MHV TRS CS may pre-
clude the template jumping step needed for sgmRNA synthesis
(29). It has been hypothesized that an interaction between PTB
and hnRNP A1, which binds to a site in the 3UTR, plays an
important role in RNA replication (20, 29, 35). If this hypoth-
esis is correct, the poor binding activity of PTB with the TRS
region would result in a failure to mediate the formation of an
RNP complex involving the 5- and 3-end fragments of the
A59/SCoV-5UTR chimeric genome (29). If so, the chimeric
genome would not be able to synthesize minus-sense gRNA.
Alternatively, the N protein and PTB might efficiently bind to
the 5 ends of A59/SCoV-5UTR/MHV-TRS and A59/SCoV-
SL3 chimeric genomes due to a good fit with the TRS, includ-
ing flanking sequences. This binding activity would enable 5-
to-3 complex formation and consequently allow the synthesis
of minus-sense gRNA. However, they would be blocked at the
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leader-body joining step of subgenomic RNA synthesis, where
a base-pairing scanning step is thought to regulate this event
(41). A lack of sufficient complementary sequence domains
would then be predicted to result in a failure to produce
sgmRNA7s. Alternatively, differences in the structures of
MHV and SCoV 5UTRs and the various chimeras could have
affected the translational efficiencies of the electroporated ge-
nomes and hence the levels of replicase proteins. In this in-
stance, differences in the amounts of replicase proteins pro-
duced in cells electroporated with different chimeras would
determine the particular RNA phenotype observed. We cur-
rently have no data on the effects (if any) that the different
chimeric 5UTRs might have on the translation of ORF1a and
ORF1b, and thus, we cannot rule out this possibility. Further
studies are needed to determine if either of these two hypoth-
eses are correct.
In spite of considerable differences in sequence, the putative
cis-acting structural elements are highly conserved and in some
cases have been demonstrated to be functionally exchangeable
among the group 2 coronaviruses. The inability of the com-
plete SCoV 5UTR to functionally replace the MHV 5UTR
suggests that recombination events between these two viruses
that yield viable recombinants will be uncommon and typically
will require two crossover events. However, the compatibility
of putative cis-acting elements within the 5UTRs and 3UTRs
from related coronaviruses suggests that with some additional
changes (mutations), viral interspecies recombination could be
facilitated. The functional studies reported here provide data
that are critical to our understanding of both the phylogenetic
relationship of SCoV to other group 2 coronaviruses and the
natural evolution of coronaviruses.
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